Chordate Medical has obtained the registration of the trademark Ozilia in the EU from EUIPO (EU Intellectual Property Office) in trademark classes 9 and 10. The company is now proceeding with applications in other suitable countries based on the priority period allowed by the registration. The new trademark represents a strategic step in the roll-out and commercialization of the migraine treatment in Chordate Medical's focus markets.

Ozilia replaces K.O.S as product name in all markets where the company operates.